Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Cancer(BTC)”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06502080
What this trial is testing

Consolidative Radiotherapy (CSRT) in Patients With Oligometastatic/Locally Advanced Unresectable Bilary Tract Cancer (BTC)

Who this might be right for
Biliary Tract Cancer
Shanghai Zhongshan Hospital 128
Testing effectiveness (Phase 2)Study completedNCT02425137
What this trial is testing

S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer(BTC)
TTY Biopharm 51
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129018
What this trial is testing

Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)First-line Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 63
Testing effectiveness (Phase 2)Looking for participantsNCT05482893
What this trial is testing

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)
Phanes Therapeutics 258
Testing effectiveness (Phase 2)UnknownNCT05350943
What this trial is testing

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Who this might be right for
Biliary Tract Adenocarcinoma
Lu Wang, MD, PhD 70
Testing effectiveness (Phase 2)Ended earlyNCT03790111
What this trial is testing

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
TerSera Therapeutics LLC 53
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Study completedNCT04217954
What this trial is testing

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Who this might be right for
Advanced Biliary Tract Cancer
Peking University 32
Early research (Phase 1)Looking for participantsNCT07197554
What this trial is testing

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid TumorsEwing SarcomaHepatocellular Carcinoma (HCC)+1 more
SEED Therapeutics, Inc. 171
Testing effectiveness (Phase 2)Looking for participantsNCT07398339
What this trial is testing

Cosiporfin Sodium for Injection Photodynamic Therapy

Who this might be right for
Biliary Tract Cancers (BTC)
Shanghai Guangsheng Biopharmaceutical Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT03531320
What this trial is testing

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

Who this might be right for
Gastrointestinal CancerBiliary Tract Cancer
InnoPharmax Inc. 19
Large-scale testing (Phase 3)UnknownNCT05429697
What this trial is testing

Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
SMT bio Co., Ltd. 128
Early research (Phase 1)Looking for participantsNCT07614061
What this trial is testing

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinoma, IntrahepaticCholangiocarcinoma, Extrahepatic+2 more
Shanghai Zhongshan Hospital 18
Not applicableLooking for participantsNCT06893380
What this trial is testing

Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer

Who this might be right for
Locally Advanced Biliary Tract CancersMetastatic Biliary Tract Cancers
CHA University 61
Large-scale testing (Phase 3)Looking for participantsNCT07229625
What this trial is testing

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

Who this might be right for
Advanced Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 604
Testing effectiveness (Phase 2)UnknownNCT06074029
What this trial is testing

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Who this might be right for
Biliary Tract CancerImmune Checkpoint InhibitorPredictive Cancer Model
Peking Union Medical College Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06919848
What this trial is testing

Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)

Who this might be right for
Biliary Tract Cancer (BTC)
Fudan University 74
Testing effectiveness (Phase 2)Study completedNCT01267344
What this trial is testing

Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC

Who this might be right for
CholangiocarcinomaAdenocarcinoma of Gallbladder
National Health Research Institutes, Taiwan 122
Load More Results